XML 14 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities    
Net loss $ (63,544) $ (35,835)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 11,972 5,443
Non-cash interest expense 21,155 5,927
Depreciation and amortization 948 1,192
Non-cash loss on issuance of convertible notes 0 26
Change in fair value of debt derivative liabilities 3,628 (1,402)
Bad debt expense 0 149
Non-cash gain on forgiveness of PPP loan (2,515) 0
Other 0 63
Changes in operating assets and liabilities:    
Accounts receivable 80 (109)
Inventory 1,575 852
Prepaid expenses and other current assets (809) 219
Other long-term assets (3,358) 4
Accounts payable 825 (420)
Accrued expenses 347 245
Accrued settlement liability   2,500
Other current liabilities 5 (251)
Other long-term liabilities (433) (418)
Net cash used in operating activities (30,124) (21,815)
Cash flows from investing activities    
Proceeds from sale of property and equipment   226
Purchase of property and equipment (47) 0
Net cash provided by (used in) investing activities (47) 226
Cash flows from financing activities    
Proceeds from issuance of convertible notes 37,225 415
Proceeds from issuance of convertible notes to related parties 11,475 15,700
Payments for issuance costs of convertible notes (95) (365)
Proceeds from PPP loan   2,515
Proceeds from exercise of stock options 74 34
Net cash provided by financing activities 48,679 18,299
Effect of exchange rate changes on cash, cash equivalents and restricted cash 0 12
Net increase (decrease) in cash, cash equivalents and restricted cash 18,508 (3,278)
Cash, cash equivalents and restricted cash at beginning of period 7,668 10,946
Cash, cash equivalents and restricted cash at end of period 26,176 7,668
Supplemental disclosures of cash flow information:    
Cash paid during the period for interest 334 452
Supplemental schedule of noncash investing and financing activities:    
Issuance of common stock warrants 21,971 7,212
Fair value of debt derivative liabilities related to issuance of convertible notes $ 26,189 $ 5,231